At TLC, we are dedicated to the development of novel nanomedicines that maximize the potential of our proprietary LipAD® lipid-assembled delivery system to enable sustained release and/or targeted deliveries that reduce toxicity and improve efficacy. We focus on creating new therapies in the areas of pain management, oncology, ophthalmology and infectious diseases. Effective drug development is a challenging and complex effort that requires the coordinated talents of many skilled individuals working as a team. If you believe in the potential for new medicines to improve quality of life and bring hope to those in need, we invite you to join us. We welcome applications from all over the globe.
View Top Employees from TLC BioSciencesWebsite | https://www.tlcbio.com |
Ticker | TLC |
Revenue | $2 million |
Funding | $50.1 million |
Employees | 33 (33 on RocketReach) |
Founded | 1997 |
Address | 3 11f-1, Nangang District, Taipei 11503, TW |
Phone | (650) 872-8816 |
Fax | +886 2 2655 7366 |
Technologies | |
Industry | Biotechnology Research, Business Services General, Nanomedicine, Business Services, Drug Delivery, Drug Discovery, Drug Development, Oncology, Ophthalmology, Pain Management, Osteoarthritis |
Competitors | AB Science, Aclaris Therapeutics, Inc., Flexion Therapeutics, Heron Therapeutics, Inc., VIVUS LLC |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 336415 Companies, NAICS Code 33641 Companies, NAICS Code 5417 Companies, NAICS Code 3364 Companies, NAICS Code 336 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 33 Companies |
Looking for a particular TLC BioSciences employee's phone or email?
The TLC BioSciences annual revenue was $2 million in 2024.
George Yeh is the President of TLC BioSciences.
33 people are employed at TLC BioSciences.
TLC BioSciences is based in Nangang District, Taipei.
The NAICS codes for TLC BioSciences are [336415, 33641, 5417, 3364, 336, 54, 541, 33].
The SIC codes for TLC BioSciences are [28, 283].